A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions

NCT06273254 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Bioequivalence Study

Interventions

DRUG: Sacubitril and Valsartan Tablets 49mg/51mg
DRUG: Entresto® (Sacubitril and Valsartan Tablets 49mg/51mg)

Sponsor

Viatris Inc.